How have ANIK and GALT total returns compared?

Over the past 10 years, ANIK delivered -8.51% and GALT delivered 13.41% annualized total return. Past performance doesn't predict future results.

Anika Therapeutics, Inc. (ANIK) vs Galectin Therapeutics Inc. (GALT)

A side-by-side comparison of Anika Therapeutics, Inc. and Galectin Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ANIK

Anika Therapeutics, Inc.

$264M

$19.73HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

GALT

Galectin Therapeutics Inc.

$247M

$3.75HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT

Total return — ANIK vs GALT

growth of $100 · dividends reinvested · last 10y

ANIK -57.8% (-8.3%/yr)GALT +293.3% (+14.7%/yr)GALT compounded faster over this window

Log scale — wide-divergence pair

ANIK GALT

ANIK vs GALT: by the numbers

•ANIK is the larger company ($264M vs $247M market cap).
•Both run net losses; GALT's is the smaller (0.00% vs -3.14% net margin).

Metrics side by side

Valuation

Metric	ANIK	GALT
Forward P/E	18.79	N/A
P/S ratio	2.19	N/A
P/B ratio	1.92	N/A
EV / EBITDA	489.09	N/A
FCF yield	0.21%	N/A

Profitability

Metric	ANIK	GALT
Gross margin	62.16%	0.00%
Operating margin	-4.24%	0.00%
Net margin	-3.14%	0.00%
ROE	-2.76%	N/A
ROIC	-3.17%	-1718.59%

Growth (annualized)

Metric	ANIK	GALT
Revenue CAGR (5Y)	-2.48%	N/A
FCF CAGR (5Y)	-39.38%	N/A
Total return CAGR (5Y)	-13.40%	0.60%

Frequently asked

How have ANIK and GALT total returns compared?: Over the past 10 years, ANIK delivered -8.51% and GALT delivered 13.41% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ANIK analysis Full GALT analysis Interactive comparison tool

Dig into the metrics

Anika Therapeutics ROE Galectin Therapeutics ROE Anika Therapeutics operating margin Galectin Therapeutics operating margin Anika Therapeutics revenue growth Galectin Therapeutics revenue growth Anika Therapeutics free cash flow Galectin Therapeutics free cash flow

Anika Therapeutics & Galectin Therapeutics appear in these rankings

Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.